Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout

Advances in Experimental Medicine and Biology

Volumn 431, Issue , 1998, Pages 57-60

  Takahashi, Sumio ^a   Yamamoto, Tetsuya ^a   Moriwaki, Yuji ^a   Tsutsumi, Zenta ^a   Yamakita, Jun Ichi ^a   Higashino, Kazuya ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; URIC ACID;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME INHIBITION; GOUT; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; RICKETS; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 0031808466     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5381-6_11     Document Type: Conference Paper

References (8)

1. Vanholder R, Patel S, Hsu CH: Effect of uric acid on plasma levels of 1,25(OH)2D3 in renal failure. J Am Soc Nephrol 4:1035-1038, 1993.
2. Lind L, Hanni A, Lithell H, Hvarfner A, Sorenson OH, Ljunghall S: Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8:894-901, 1995.
3. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E: Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 27:181-188, 1995.
4. Stamp TCB, Round JM: Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 247:563-565, 1974.
5. Kerstetter J, Caballero B, O'Brien K, Wurtrman R, Allen L: Mineral homeostasis in obesity: effect of euglycemic hyperinsulinemia. Metabolism 40:707-713, 1991.
6. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH: Low circulating vitamin D in obesity. Calcif Tissue Int 43:199-201, 1988.
7. Scragg R, Holdaway I, Jackson R, Lim T: Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. Ann Epidemiol 2:697-703, 1992.
8. Kokot F, Pietrek J, Srokowska S, et al: 25-hydroxyvitamin D in patients with essential hypertension. Clin Nephrol 16:188-192, 1981.